Deprescribing: An Application to Medication Management in Older Adults

Long-Term Efficacy and Toxicity of Cholinesterase Inhibitors in the Treatment of Alzheimer Disease

(2017) David B Hogan   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer Disease

(2016) Nathan Herrmann et al.   Journal of the American Medical Directors Association

The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer’s Disease

(2015) William James Deardorff et al.   DRUGS & AGING

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

(2015) Erik S. Stroes et al.   EUROPEAN HEART JOURNAL

The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)

(2015) Dennis M. Black et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Evaluation of a Pharmacist-Led Medication Assessment Used to Identify Prevalence of and Associations With Polypharmacy and Potentially Inappropriate Medication Use Among Ambulatory Senior Adults With Cancer

(2015) Ginah Nightingale et al.   JOURNAL OF CLINICAL ONCOLOGY

Cholinesterase Inhibitor Discontinuation in Patients With Alzheimer’s Disease

(2015) Jordana O’Regan et al.   JOURNAL OF CLINICAL PSYCHIATRY

American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

(2015)   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Older peoples’ attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia

(2015) Katie Qi et al.   International Journal of Clinical Pharmacy

Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness

(2015) Jean S. Kutner et al.   JAMA Internal Medicine

Reducing Inappropriate Polypharmacy

(2015) Ian A. Scott et al.   JAMA Internal Medicine

What Are Priorities for Deprescribing for Elderly Patients? Capturing the Voice of Practitioners: A Modified Delphi Process

(2015) Barbara Farrell et al.   PLoS One

STOPP/START criteria for potentially inappropriate prescribing in older people: version 2

(2014) Denis O'Mahony et al.   AGE AND AGEING

Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care

(2014) Rupert A. Payne et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Health Outcomes Associated with Polypharmacy in Community-Dwelling Older Adults: A Systematic Review

(2014) Terri R. Fried et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

How long should we treat?

(2014) C. Roux et al.   OSTEOPOROSIS INTERNATIONAL

Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians

(2013) Amir Qaseem   ANNALS OF INTERNAL MEDICINE

Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review

(2013) Erik F. Eriksen et al.   BONE

Controversies in Osteoporosis Management

(2013) MICHAEL MCCLUNG   CLINICAL OBSTETRICS AND GYNECOLOGY

Patient Barriers to and Enablers of Deprescribing: a Systematic Review

(2013) Emily Reeve et al.   DRUGS & AGING

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

People's Attitudes, Beliefs, and Experiences Regarding Polypharmacy and Willingness to Deprescribe

(2013) Emily Reeve et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

ESC/EAS Guidelines for the management of dyslipidaemias

(2011) Alberico L. Catapano et al.   ATHEROSCLEROSIS

Preventable and Non-Preventable Adverse Drug Events in Hospitalized Patients

(2011) Aileen B. Dequito et al.   DRUG SAFETY

Fracture risk associated with continuation versus discontinuation of bisphosphonates after 5 years of therapy in patients with primary osteoporosis: a systematic review and meta-analysis

(2011) Fraser et al.   Therapeutics and Clinical Risk Management

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials

(2010) E. J. Mills et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Polypharmacy Status as an Indicator of Mortality in an Elderly Population

(2009) Johanna Jyrkkä et al.   DRUGS & AGING

Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United States

(2008)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION